S&P 500   5,069.76 (-0.17%)
DOW   38,949.02 (-0.06%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   5.00 (+3.95%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
S&P 500   5,069.76 (-0.17%)
DOW   38,949.02 (-0.06%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   5.00 (+3.95%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
S&P 500   5,069.76 (-0.17%)
DOW   38,949.02 (-0.06%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   5.00 (+3.95%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)
S&P 500   5,069.76 (-0.17%)
DOW   38,949.02 (-0.06%)
QQQ   435.27 (-0.53%)
AAPL   181.42 (-0.66%)
MSFT   407.72 (+0.06%)
META   484.02 (-0.62%)
GOOGL   136.38 (-1.80%)
AMZN   173.16 (-0.22%)
TSLA   202.04 (+1.16%)
NVDA   776.63 (-1.32%)
NIO   5.44 (-6.05%)
AMD   176.54 (-0.82%)
BABA   74.60 (-3.96%)
T   16.96 (+0.77%)
F   12.30 (+2.50%)
MU   89.71 (-2.33%)
CGC   3.36 (-4.82%)
GE   155.61 (+1.05%)
DIS   110.80 (+1.26%)
AMC   5.00 (+3.95%)
PFE   27.04 (+0.56%)
PYPL   60.25 (+0.15%)
XOM   104.37 (+0.33%)

Achilles Therapeutics (ACHL) News Today

$1.57
+0.08 (+5.37%)
(As of 02/28/2024 ET)
SourceHeadline
wsj.com logoAchilles Therapeutics PLC ADR
wsj.com - February 22 at 5:29 PM
benzinga.com logoAchilles Therapeutics Stock (NASDAQ:ACHL), Short Interest Report
benzinga.com - February 22 at 5:29 PM
investing.com logoAchilles Therapeutics PLC ADR (ACHL)
investing.com - February 9 at 6:38 PM
finance.yahoo.com logoAchilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
finance.yahoo.com - February 5 at 8:25 AM
benzinga.com logoAchilles Therapeutics Stock (NASDAQ:ACHL) Dividends: History, Yield and Dates
benzinga.com - December 22 at 12:49 AM
seekingalpha.com logoACHL Achilles Therapeutics plc
seekingalpha.com - December 20 at 6:06 PM
finance.yahoo.com logoAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
finance.yahoo.com - December 18 at 8:16 AM
foxnews.com logoSteelers lose Kwon Alexander for season with torn Achilles: reports
foxnews.com - November 22 at 12:45 AM
msn.com logoAchilles Therapeutics GAAP EPS of -$0.42 misses by $0.02
msn.com - November 14 at 8:14 AM
foxnews.com logoAs Aaron Rodgers rehabs from torn Achilles, doctor offers insight into recovery
foxnews.com - October 29 at 10:22 PM
finanznachrichten.de logoAchilles Therapeutics PLC: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
finanznachrichten.de - September 23 at 6:51 AM
uk.style.yahoo.com logoAre Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?
uk.style.yahoo.com - September 22 at 3:54 PM
usatoday.com logoAaron Rodgers says he's starting 'road to recovery' after Achilles surgery went 'great'
usatoday.com - September 21 at 9:03 AM
usatoday.com logoJets QB Aaron Rodgers to miss rest of NFL season with torn Achilles
usatoday.com - September 17 at 6:24 AM
dailymail.co.uk logoAaron Rodgers said he was 'manifesting' a Super Bowl run for the Jets in interview with John McEnroe that aired just MINUTES before he suffered season-ending Achilles injury
dailymail.co.uk - September 14 at 8:17 PM
cbsnews.com logoAaron Rodgers' Achilles injury is "not good," Jets head coach says, as star quarterback is set to get MRI
cbsnews.com - September 14 at 8:17 PM
finance.yahoo.com logoIs KalVista Pharmaceuticals (KALV) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - September 6 at 5:24 PM
msn.com logoChardan Capital Reiterates Achilles Therapeutics Plc - ADR (ACHL) Buy Recommendation
msn.com - August 7 at 10:06 AM
finance.yahoo.com logoAchilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
finance.yahoo.com - August 4 at 5:33 PM
finanznachrichten.de logoAchilles Therapeutics PLC: Achilles Therapeutics to Present at Upcoming Conferences
finanznachrichten.de - June 12 at 7:17 PM
msn.com logoAchilles Therapeutics: Q1 Earnings Insights
msn.com - May 11 at 6:51 PM
seekingalpha.com logoAchilles Therapeutics GAAP EPS of -$0.44
seekingalpha.com - May 10 at 5:49 PM
finanznachrichten.de logoAchilles Therapeutics PLC: Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
finanznachrichten.de - May 10 at 12:48 PM
finance.yahoo.com logoAchilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens
finance.yahoo.com - May 10 at 7:48 AM
finance.yahoo.com logoAchilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
finance.yahoo.com - May 10 at 7:48 AM
finance.yahoo.com logoAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
finance.yahoo.com - April 25 at 9:08 PM
finance.yahoo.com logoAchilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA Status
finance.yahoo.com - April 25 at 10:50 AM
finance.yahoo.com logoAchilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
finance.yahoo.com - April 17 at 8:05 AM
health.usnews.com logoGerard Achilles M. Obnial
health.usnews.com - March 24 at 10:42 PM
dailymail.co.uk logoMe and my operation: achilles tendon surgery
dailymail.co.uk - March 24 at 7:40 AM
finanznachrichten.de logoAchilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business Highlights
finanznachrichten.de - March 7 at 11:09 AM
finance.yahoo.com logoAchilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business Highlights
finance.yahoo.com - March 7 at 11:09 AM
finance.yahoo.com logoIs Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - January 17 at 1:12 PM
finance.yahoo.com logoAchilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 20 at 1:12 PM
finance.yahoo.com logoAchilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022
finance.yahoo.com - December 6 at 8:48 AM
finance.yahoo.com logoAchilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022
finance.yahoo.com - November 30 at 9:40 PM
finance.yahoo.com logoAchilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method
finance.yahoo.com - November 22 at 7:38 PM
finance.yahoo.com logoIs Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - November 13 at 1:48 PM
finance.yahoo.com logoAchilles Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
finance.yahoo.com - November 8 at 11:20 AM
finance.yahoo.com logoAchilles Therapeutics Co-founder Professor Charles Swanton to Participate in Expert Roundtable Highlighting Pivotal Nature of Neoantigens as Targets in Cancer Cell Therapy
finance.yahoo.com - October 6 at 8:41 AM
nasdaq.com logoAchilles Therapeutics plc (NASDAQ:ACHL) stock most popular amongst private equity firms who own 51%, while individual investors hold 22%
nasdaq.com - September 26 at 8:16 PM
reuters.com logoAchilles Therapeutics PLC
reuters.com - September 12 at 8:59 PM
finance.yahoo.com logoGilead's (GILD) Tecartus Gets EC Nod for New Cancer Indication
finance.yahoo.com - September 7 at 4:48 PM
finance.yahoo.com logoCuris (CRIS) Gets FDA Nod to Partly Resume Leukemia Study
finance.yahoo.com - August 31 at 4:18 PM
finance.yahoo.com logoAstraZeneca (AZN) Gets Japan Nod for Expanded Use of 3 Drugs
finance.yahoo.com - August 25 at 3:20 PM
finance.yahoo.com logoHorizon (HZNP) Inks Collaboration Deal with Q32 Bio for ADX-914
finance.yahoo.com - August 16 at 12:33 PM
finance.yahoo.com logoAchilles Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
finance.yahoo.com - August 9 at 11:51 AM
finance.yahoo.com logoWhat Is The Ownership Structure Like For Achilles Therapeutics plc (NASDAQ:ACHL)?
finance.yahoo.com - August 1 at 8:58 AM
morningstar.com logoAchilles Therapeutics PLC ADR - Stock Quote ACHL
morningstar.com - July 6 at 10:51 PM
finanznachrichten.de logoAchilles Therapeutics PLC: Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board
finanznachrichten.de - June 30 at 8:28 AM
Get Achilles Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter.



ACHL Media Mentions By Week

ACHL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACHL
News Sentiment

0.93

0.70

Average
Medical
News Sentiment

ACHL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACHL Articles
This Week

4

0

ACHL Articles
Average Week

Get Achilles Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ACHL) was last updated on 2/28/2024 by MarketBeat.com Staff